GRFS
Grifols SA ADRNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$5.31B
P/E Ratio
11.14
EPS
$0.70
Beta
1.17
52W High
$10.96
52W Low
$7.39
50-Day MA
$8.17
200-Day MA
$9.14
Dividend Yield
2.25%
Profit Margin
5.58%
Forward P/E
9.06
PEG Ratio
0.23
About Grifols SA ADR
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
Fundamentals
| Revenue (TTM) | $7.44B |
| Gross Profit (TTM) | $2.85B |
| EBITDA | $1.68B |
| Operating Margin | 16.50% |
| Return on Equity | 6.13% |
| Return on Assets | 4.21% |
| Revenue/Share (TTM) | $5.46 |
| Book Value | $4.52 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 0.71 |
| EV/Revenue | 1.9 |
| EV/EBITDA | 8.71 |
| Quarterly Earnings Growth (YoY) | 43.50% |
| Quarterly Revenue Growth (YoY) | -4.80% |
| Shares Outstanding | $680.58M |
| Float | $417.31M |
| % Insiders | 0.00% |
| % Institutions | 57.79% |
Historical Volatility
HV 10-Day
42.76%
HV 20-Day
37.21%
HV 30-Day
37.97%
HV 60-Day
38.61%
HV Rank
79.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($10.87 target)
1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026